Focusing on individuals at high risk for melanoma may improve the cost-effectiveness and the benefit-to-harm balance of melanoma screening programmes, according to authors of this German study.
In a large cohort of patients undergoing sentinel node biopsy (SNB), completion lymphadenectomy was not shown to increase survival, confirming that SNB provides prognostic information but not therapeutic benefit.
Patients with Parkinson's disease (PD) have about a 4-fold increased risk of having pre-existing melanoma and those with melanoma have a similar risk of developing PD, according to new retrospective, case-control analyses.
Findings of a study among Irish teenagers found that there was no reduction of sunbed use in teenagers two years after the introduction of legislation banning its use in those aged < 18 years.
Early life UV but not cumulative UV appears to increase BCC risk, and SCC risk appears only to be related to long-term cumulative sun exposure, according to authors of this Australian study.
While acral lentiginous melanoma has the same prognostic factors as the other subtypes of melanoma, its unfavourable prognosis probably is due to the delay of diagnosis in comparison to other melanoma subtypes, according to authors of this German study.
“Adolescents spend a considerable amount of time using social networking sites, and their behaviours related to tanning on these sites are significantly associated with skin cancer risk factors”, according to authors of this Australian study.
“At about $50 million per year for hospitals in Victoria alone, the cost burden of a largely preventable disease is substantial,” according to authors of this Australian study. They conclude that “increased funding for skin cancer prevention must be kept high on the public health agenda”.
Patients with advanced melanoma after treatment with ipilimumab (Yervoy) had similar survival with nivolumab (Opdivo) or chemotherapy, despite more frequent and more durable responses with the PD-1 inhibitor, results of a randomized trial showed.
Results of recent research identify a pathway toward UV-independent topical modulation of human skin pigmentation, potentially impacting UV protection and skin cancer risk.